GENOSCORE-ACT
DEAD

Serial Number

98203382

Owner

Cytox Limited

Attorney

Anne F. Downey

Filing Date

Sep 29, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GENOSCORE-ACT Trademark

Serial Number: 98203382

GENOSCORE-ACT is a trademark filed by Cytox Limited on September 29, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cytox Limited (7 trademarks)

Work.Life Core,

Entity Type: 99

Trademark Details

Filing Date

September 29, 2023

Registration Date

Not Registered

Goods & Services

Software algorithms programs to aid early diagnosis of degenerative diseases, particularly Alzheimer's; computer software to aid early diagnosis of degenerative diseases, particularly Alzheimer's; software algorithms programs to aid early diagnosis of progressive diseases, particularly Alzheimer's; computer software to aid early diagnosis of progressive diseases, particularly Alzheimer's

Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical treatment services; cognitive therapy services; cognitive and psychological examination and testing services; information, advice and consultancy in relation to all the aforesaid services; all the aforesaid being in the fields of dementia and cognitive decline

Software as a service; advisory services relating to science; analysis of human tissues for medical research; biochemical research, development and analysis; biological research, development and analysis; biotechnological research, development and analysis; chemical research and analysis; clinical research; consultancy relating to laboratory testing; laboratory research; laboratory services; medical research; providing temporary use of non-downloadable computer software for accessing and using a cloud computing network; providing temporary use of web-based software; providing temporary use of non-downloadable computer software; research and development services in the field of gene expression systems; providing temporary use of non-downloadable computer software to aid early diagnosis of degenerative diseases; providing temporary use of non-downloadable computer software to aid early diagnosis of progressive diseases; software as a service to aid early diagnosis of degenerative diseases; software as a service to aid early diagnosis of progressive diseases; scientific risk assessment

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 16, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 16, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 29, 2024 CNRT
ASSIGNED TO EXAMINER
May 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
NEW APPLICATION ENTERED
Oct 3, 2023 NWAP